Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

421 ARTÍCULOS , VIENDO DEL 151 AL 165

Restless legs syndrome in Egyptian medical students using a validated Arabic version of the Restless Legs Syndrome Rating Scale

Shalash AS, Elrassas HH, Monzem MM, Salem HH, Abdel Moneim A, Moustafa RR.

Sleep Med. 2015 Dec;16(12):1528-31. doi: 10.1016/j.sleep.2015.07.032. Epub 2015 Sep 25.

Nonpharmacologic Management of Chronic Insomnia

Maness DL, Khan M.

Am Fam Physician. 2015 Dec 15;92(12):1058-64.

Higher frequency of certain cancers in LRRK2 G2019S mutation carriers with Parkinson disease: a pooled analysis

Agalliu I, San Luciano M, Mirelman A, Giladi N, Waro B, Aasly J, Inzelberg R, Hassin-Baer S, Friedman E, Ruiz-Martinez J, Marti-Masso JF, Orr-Urtreger A, Bressman S, Saunders-Pullman R.

JAMA Neurol. 2015 Jan;72(1):58-65. doi: 10.1001/jamaneurol.2014.1973.

Development of the Tampa Scale of Kinesiophobia for Parkinson's disease: confirmatory factor analysis, reliability, validity and sensitivity to change

Monticone M, Ferrante S, Ambrosini E, Rocca B, Secci C, Foti C.

Int J Rehabil Res. 2015 Jun;38(2):113-20. doi: 10.1097/MRR.0000000000000095.

Combined rasagiline and antidepressant use in Parkinson disease in the ADAGIO study: effects on nonmotor symptoms and tolerability

Smith KM, Eyal E, Weintraub D; ADAGIO Investigators.

JAMA Neurol. 2015 Jan;72(1):88-95. doi: 10.1001/jamaneurol.2014.2472.

[Anesthesiological management of awake craniotomy : Asleep-awake-asleep technique or without sedation]

Seemann M, Zech N, Graf B, Hansen E.

Anaesthesist. 2015 Feb;64(2):128-36. doi: 10.1007/s00101-014-2396-6.

Proceedings of the Second Annual Deep Brain Stimulation Think Tank: What's in the Pipeline

Gunduz A, Morita H, Rossi PJ, Allen WL, Alterman RL, Bronte-Stewart H, Butson CR, Charles D, Deckers S, de Hemptinne C, DeLong M, Dougherty D, Ellrich J, Foote KD, Giordano J, Goodman W, Greenberg BD, Greene D, Gross R, Judy JW, Karst E, Kent A, Kopell B, Lang A, Lozano A, Lungu C, Lyons KE, Machado A, Martens H, McIntyre C, Min HK, Neimat J, Ostrem J, Pannu S, Ponce F, Pouratian N, Reymers D, Schrock L, Sheth S, Shih L, Stanslaski S, Steinke GK, Stypulkowski P, Tröster AI, Verhagen L, Walker H, Okun MS.

Int J Neurosci. 2015;125(7):475-85. doi: 10.3109/00207454.2014.999268. Epub 2015 May 25.

Neurodegeneration with brain iron accumulation: diagnosis and management

Hogarth P.

J Mov Disord. 2015 Jan;8(1):1-13. doi: 10.14802/jmd.14034. Epub 2015 Jan 13.

Insights on the interaction of alpha-synuclein and metals in the pathophysiology of Parkinson's disease

Carboni E, Lingor P.

Metallomics. 2015 Mar;7(3):395-404. doi: 10.1039/c4mt00339j.

Amantadine extended release for levodopa-induced dyskinesia in Parkinson's disease (EASED Study)

Pahwa R, Tanner CM, Hauser RA, Sethi K, Isaacson S, Truong D, Struck L, Ruby AE, McClure NL, Went GT, Stempien MJ.

Mov Disord. 2015 May;30(6):788-95. doi: 10.1002/mds.26159. Epub 2015 Feb 4.

Is Parkinson's disease truly a prion-like disorder? An appraisal of current evidence

Chauhan A, Jeans AF.

Neurol Res Int. 2015;2015:345285. doi: 10.1155/2015/345285. Epub 2015 Jan 13.

[The genetics of antipsychotic-related movement disorders]

Bakker PR, van Os J, van Harten PN.

Tijdschr Psychiatr. 2015;57(2):114-9.

Targeting histone deacetylases: a novel approach in Parkinson's disease

Sharma S, Taliyan R.

Parkinsons Dis. 2015;2015:303294. doi: 10.1155/2015/303294. Epub 2015 Jan 28.

The endosomal pathway in Parkinson's disease

Perrett RM, Alexopoulou Z, Tofaris GK.

Mol Cell Neurosci. 2015 May;66(Pt A):21-8. doi: 10.1016/j.mcn.2015.02.009. Epub 2015 Feb 19.

The discovery of human auditory-motor entrainment and its role in the development of neurologic music therapy

Thaut MH.

Prog Brain Res. 2015;217:253-66. doi: 10.1016/bs.pbr.2014.11.030. Epub 2015 Feb 2.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias